"Piperazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D010879
|
MeSH Number(s) |
D03.383.606
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Piperazines".
Below are MeSH descriptors whose meaning is more specific than "Piperazines".
This graph shows the total number of publications written about "Piperazines" by people in this website by year, and whether "Piperazines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 0 | 2 | 2 |
1998 | 1 | 1 | 2 |
1999 | 3 | 1 | 4 |
2000 | 2 | 2 | 4 |
2001 | 7 | 2 | 9 |
2002 | 19 | 5 | 24 |
2003 | 42 | 11 | 53 |
2004 | 36 | 14 | 50 |
2005 | 22 | 13 | 35 |
2006 | 38 | 26 | 64 |
2007 | 41 | 40 | 81 |
2008 | 44 | 32 | 76 |
2009 | 45 | 33 | 78 |
2010 | 50 | 26 | 76 |
2011 | 31 | 24 | 55 |
2012 | 25 | 29 | 54 |
2013 | 28 | 19 | 47 |
2014 | 18 | 17 | 35 |
2015 | 13 | 13 | 26 |
2016 | 6 | 9 | 15 |
2017 | 9 | 3 | 12 |
2018 | 8 | 10 | 18 |
2019 | 9 | 14 | 23 |
2020 | 7 | 11 | 18 |
2021 | 14 | 21 | 35 |
2022 | 1 | 9 | 10 |
2023 | 5 | 2 | 7 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Piperazines" by people in Profiles.
-
Dolutegravir-induced neural tube defects in mice are folate responsive. AIDS. 2024 Mar 15; 38(4):439-446.
-
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial. Nat Med. 2024 Jan; 30(1):265-270.
-
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program. Viruses. 2023 Dec 23; 16(1).
-
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma. Br J Cancer. 2024 02; 130(3):476-482.
-
Measures of functional status in older patients treated with palbociclib for advanced breast cancer. J Geriatr Oncol. 2024 Jan; 15(1):101670.
-
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary. Future Oncol. 2024 Jan; 20(3):113-120.
-
Outcomes of male patients with HR+/HER2- advanced breast cancer receiving palbociclib in the real-world POLARIS study. Breast Cancer Res Treat. 2024 Feb; 203(3):463-475.
-
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial. J Clin Oncol. 2024 Jan 20; 42(3):283-299.
-
How erastin assassinates cells by ferroptosis revealed. Protein Cell. 2023 03 16; 14(2):84-86.
-
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors. J Biol Chem. 2022 08; 298(8):102226.